# MEDICOMPARE INDIA — GATE 1 INDEPENDENT REQUIREMENTS REVIEW

**Document ID:** `REV-GATE1-001`  
**Target Document:** `DOC-SRS-001` (`docs/02-requirements/srs.md`)  
**Target Document Version:** 1.0.0  
**Target Document Author:** AGENT 02 — Business Analyst  
**Reviewing Agent:** AGENT 01 — Product Strategy  
**Quality Gate:** GATE 1 — Requirements Review  
**Date:** 2026-11-08  
**Decision:** **APPROVED**  

---

## 1. Executive Summary & Review Decision

As **AGENT 01 — Product Strategy**, I have conducted an independent requirements review of the IEEE Std 830-1998 / ISO/IEC/IEEE 29148:2018 compliant Software Requirements Specification (`DOC-SRS-001`) authored by Agent 02.

The specification provides an authoritative, rigorously structured, and comprehensive definition of MediCompare India's product capabilities, technical constraints, regulatory boundaries, and verification methods. It adheres strictly to the modular monolith architecture, DPDP Act 2023 privacy directives, Drugs and Cosmetics Rules 1945 retail licensing boundaries, and data integrity safeguards defined in `AGENTS.md` and `.agents/rules/`.

**Official Decision: APPROVED FOR GATE 1**

---

## 2. Evaluation Matrix Against Strategic Criteria

| Evaluation Dimension | Assessment Criteria | Findings & Evidence in DOC-SRS-001 | Compliance Status |
| :--- | :--- | :--- | :--- |
| **1. Functional Requirements (FR-001 to FR-028)** | Uniquely numbered, verifiable, and strictly aligned with core value proposition. | • 28 functional requirements sequentially indexed from FR-001 through FR-028 across 7 coherent modules.<br>• Every requirement specifies explicit inputs, processing logic, expected outputs, and assigned verification method (Unit, Integration, E2E, Database, Security/RLS, Accessibility).<br>• Core value proposition is directly mapped: exact formulation matching (FR-001–FR-005), price comparison & provenance (FR-006–FR-011), local pharmacy geospatial discovery (FR-012–FR-016), statutory safety (FR-017–FR-019), pharmacy onboarding (FR-020–FR-022), CSV inventory ingestion (FR-023–FR-025), and governance/audit logs (FR-026–FR-028). | **COMPLIANT (100%)** |
| **2. Non-Dispensing Boundary & DPDP Compliance** | Strict exclusion of online medicine sales, courier delivery, prescription storage, and clinical recommendations; privacy-by-design search. | • Section 1.2 explicitly defines out-of-scope non-dispensing boundaries: no online drug sales, no compounding, no courier fulfillment, no prescription scan storage, no clinical recommendations.<br>• Section 3.4 (FR-017 & FR-018) mandates persistent non-dispensing statutory banners and Schedule H/H1 "Rx Required" warnings requiring physical prescription presentation at the retail counter.<br>• Section 4.2 (NFR-SEC01 & NFR-SEC02) enforces anonymous search by default (zero registration required for search) and client-side ephemeral geolocation with zero persistent logging of coordinates.<br>• Fully harmonized with Regulatory Framework (`DOC-REG-001`). | **COMPLIANT (100%)** |
| **3. User Classes & MVP Boundaries** | Realistic scoping of Patient, Pharmacy Operator, and Platform Admin personas without enterprise bloat. | • **Patient/Consumer**: Anonymous public consumer. Immediate access to search, formulation resolution, price comparison, distance radius filtering, map navigation, and incorrect price reporting.<br>• **Pharmacy Operator**: Authenticated via Supabase Auth and isolated via RLS. Drug License (Form 20/21) onboarding, manual price/stock dashboard, batch CSV ingestion.<br>• **Platform Admin**: Verification queue for drug licenses against State Drug Control registers, immutable audit logs, catalog curation.<br>• Strict boundary enforcement: Unverified pharmacies cannot publish prices to the public (FR-022). No complex e-commerce, tele-consultation, or courier fleet overhead. | **COMPLIANT (100%)** |
| **4. Non-Functional Requirements Quantification** | Concrete, measurable metrics rather than subjective adjectives. | • **Performance**: Autocomplete search latency **< 300 ms** (NFR-P01), spatial/comparison backend queries **< 150 ms** (NFR-P02), Core Web Vitals (LCP < 2.5s, FID/INP < 100ms, CLS < 0.1) (NFR-P03), initial client bundle **< 150 KB gzip** via dynamic import of Leaflet (NFR-P04).<br>• **Security & Privacy**: 100% tables with RLS (NFR-SEC03), 0 service_role exposure (NFR-SEC04), 100% HTTPS TLS 1.3 / HSTS (NFR-SEC05).<br>• **Clinical Safety**: 0 approximate name substitutions (NFR-SAF01), 100% statutory disclaimers on prescription views (NFR-SAF02), 0 diagnostic/treatment algorithms (NFR-SAF03).<br>• **Accessibility**: WCAG 2.1 Level AA with >= 4.5:1 text contrast (NFR-ACC01), responsive 360px–1920px (NFR-ACC02), touch targets >= 44px × 44px (NFR-ACC03). | **COMPLIANT (100%)** |

---

## 3. Product Strategy Observations & Post-MVP Guidance

While the SRS is fully approved for MVP execution, the following observations are logged for future sprint cycles:

1. **Price Freshness Decay Rule (Post-MVP Enhancement)**:
   - FR-010 establishes visual badges for price confirmation (Green < 24h, Amber < 7d, Red > 7d). In Phase 2, a scheduled background cron job should automatically transition quotations older than 14 days to `STALE_UNCONFIRMED` status to safeguard consumer trust.
2. **Localization (Phase 2 Roadmap)**:
   - For Bengaluru and wider Karnataka adoption, an i18n localization pipeline (Kannada UI labels) should be added post-MVP while preserving standard chemical INN salt names in English.
3. **Data Provenance Visual Hierarchy**:
   - In accordance with Governance Rule 02, UI design must strictly ensure that Government NPPA Ceiling Prices (`FR-008`) use a neutral reference badge (e.g., Slate badge), while verified local pharmacy selling prices (`FR-007`) use distinct active commerce styling (Emerald `#059669`), preventing any consumer confusion.

---

## 4. Formal Review Sign-Off Statement

```
================================================================================
QUALITY GATE 1 SIGN-OFF RECORD
================================================================================
Document Under Review : DOC-SRS-001 (Software Requirements Specification v1.0.0)
Task ID               : MC-003
Reviewing Agent       : AGENT 01 — Product Strategy
Quality Gate          : GATE 1 — Requirements Review
Review Status         : APPROVED
Verification Date     : 2026-11-08

Statement:
"As Agent 01 (Product Strategy), I have evaluated DOC-SRS-001 against MediCompare
India's core product vision, MVP prioritization guidelines, and governance
rules. The 28 Functional Requirements are uniquely numbered, verifiable, and
aligned with our exact formulation matching and local pharmacy discovery
mission. The non-dispensing legal boundary and DPDP Act privacy safeguards are
uncompromisingly reflected across functional and non-functional specifications.
All non-functional requirements are quantified and verifiable.

DOC-SRS-001 is hereby formally APPROVED for Quality Gate 1."

Signed:
AGENT 01 — Product Strategy
MediCompare India Platform
================================================================================
```
